Abstract:Hepatocellular carcinoma (HCC) is one of the leading malignancies worldwide. Myocyte enhancer factor 2C (MEF2C) was traditionally regarded as a development-associated factor and was recently reported to be an oncogene candidate. We have previously reported overexpression of MEF2C in HCC; however, the roles of MEF2C in HCC remain to be clarified. In this study, HCC cell lines and a xenograft mouse model were used to determine the functions of MEF2C in vitro and in vivo , respectively. Specific plasmids and small interfering RNA were used to upregulate and downregulate MEF2C expression, respectively. Functional assays were performed to assess the influence of MEF2C on cell proliferation, and VEGF-induced vasculogenic mimicry, migration/invasion as well as angiogenesis. Co-immunoprecipitation was conducted to identify the interaction of MEF2C and β-catenin. Human HCC tissue microarrays were used to investigate correlations among MEF2C, β-catenin and involved biomarkers. MEF2C was found to mediate VEGF-induced vasculogenic mimicry, angiogenesis and migration/invasion, with involvement of the p38 MAPK and PKC signaling pathways. However, MEF2C itself inhibited tumor growth in vitro and in vivo . MEF2C was upregulated by and directly interacted with β-catenin. The nuclear translocation of β-catenin blocked by MEF2C was responsible for MEF2C-mediated growth inhibition. The nuclear translocation of MEF2C was associated with intracellular calcium signaling induced by β-catenin. HCC microarrays showed correlations of nuclear MEF2C with the angiogenesis-associated biomarker, CD31, and cytosolic MEF2C with the proliferation-associated biomarker, Ki-67. MEF2C showed double-edged activities in HCC, namely mediating VEGF-induced malignancy enhancement while inhibiting cancer proliferation via blockade of Wnt/β-catenin signaling. The overall effect of MEF2C in HCC progression regulation was dictated by its subcellular distribution. This should be determined prior to any MEF2C-associated intervention in HCC.

Mitofusin-2 Triggers Mitochondria Ca2+ Influx from the Endoplasmic Reticulum to Induce Apoptosis in Hepatocellular Carcinoma Cells.

Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells

Clinical Significance of Mitofusin-2 and Its Signaling Pathways in Hepatocellular Carcinoma

Role of mitofusin-2 in high mobility group box-1 protein-mediated apoptosis of T cells in vitro.

Mitofusin 2 Triggers Vascular Smooth Muscle Cell Apoptosis Via Mitochondrial Death Pathway

Mitofusin2 Induces Cell Autophagy of Pancreatic Cancer through Inhibiting the PI3K/Akt/mTOR Signaling Pathway

Mitofusin-2 Mediated Mitochondrial Ca2+ Uptake 1/2 Induced Liver Injury in Rat Remote Ischemic Perconditioning Liver Transplantation and Alpha Mouse Liver-12 Hypoxia Cell Line Models.

Mitofusin-2 is a Major Determinant of Oxidative Stress-mediated Heart Muscle Cell Apoptosis

Doxorubicin-induced Cardiomyocyte Apoptosis: Role of Mitofusin 2.

Hepatitis B Virus X Protein Inhibits P53-Mediated Upregulation of Mitofusin-2 in Hepatocellular Carcinoma Cells

MEF2D Facilitates Liver Metastasis of Gastric Cancer Cells Through Directly Inducing H1X under IL-13 Stimulation

Silencing MFN2 Drives WNT/β-catenin Nucleation to Reduce Sorafenib Sensitivity in Hepatocellular Carcinoma Cells

Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling

Mitofusin 2 Promotes Apoptosis of CD4+ T Cells by Inhibiting Autophagy in Sepsis

Combination Of Interferon-Alpha And 5-Fluorouracil Induces Apoptosis Through Mitochondrial Pathway In Hepatocellular Carcinoma In Vitro

Upregulation of Microfibrillar-Associated Protein 2 is Closely Associated with Tumor Angiogenesis and Poor Prognosis in Hepatocellular Carcinoma.

FUNDC2 Promotes Liver Tumorigenesis by Inhibiting MFN1-mediated Mitochondrial Fusion

Knockdown Expression of MECR, a Novel Gene of Mitochondrial FAS II Inhibits Growth and Colony-Formation, Promotes Apoptosis of Hepatocelluar Carcinoma Cells.

MCUR1-mediated mitochondrial calcium signaling facilitates cell survival of hepatocellular carcinoma via ROS-dependent P53 degradation.

Mitofusin 1 is negatively regulated by microRNA 140 in cardiomyocyte apoptosis.

Mitofusin2, As a Protective Target in the Liver, Controls the Balance of Apoptosis and Autophagy in Acute-on-Chronic Liver Failure